In Vitro Activities of 2,2'-Dipyridyl Against Trichomonas vaginalis, Candida albicans, and Gardnerella vaginalis

  • Ryu, Jae-Sook (Department of Parasitology, Hanyang University College of Medicine) ;
  • Min, Duk-Young (Department of Parasitology, Hanyang University College of Medicine) ;
  • Kim, Myeong-Cheol (Department of Parasitology, Hanyang University College of Medicine) ;
  • Kim, Nam-Sik (Department of Parasitology, Hanyang University College of Medicine) ;
  • Shin, Myeong-Heon (Department of Parasitology, College of Medicine, Ewha Womans University)
  • Published : 2001.02.01

Abstract

The in vitro activities of 2,2'-dipyridyl, an iron-chelator, against clinical isolates of Trichomonas vaginalis, Candida albicans, and Gardnerella vaginalis was evaluated and compared with those of four other vaginal suppositories, ornidazole, clotrimazole, povidone-iodine, and $Cenacert^{\circledR}$ (Methylbezethonium Chloride mixed with 9-aminoacrydine undecylenate and hydrochloric acid N-myristyl-3-hydroxy butyl amine). The 2,2'-dipyridyl killed T. vaginalis and G. vaginalis at concentrations of $410\;{\mu}g/ml$ and $205\;{\mu}g/ml$, respectively, however, ths agent was less active against C. albicans (80% of which was inhiited at $410\;{\mu}g/ml$). The inhibition of these three pathogens by 2,2'-dipyridyl was similar to clotrimazole. In addition, the effect of 2,2'-dipyridyl on the ultrastructure of T. vaginalis, C. albicans, an G. vaginalis was examined. Transmission electron microscopy indicated that 2,2'-dipyridyl induced modifications of the cellular contents and cell envolope concumitant with the degradation of the three pathogens. These results suggest that 2,2'-dipyridyl has an inhibitory effect on C. albicans and G. vaginalis, as well as T. vaginalis.

Keywords

References

  1. Sex Transm. Infect. v.74 Recurrent bacterial vaginosis and metronidazole resistance in Gardnerella vaginalis Bannatyne, R. M.;A. M. Smith
  2. MMWR Morb. Mortal Wkly. Rep. v.24 no.42(RR-14) Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention Centers for Disease Control
  3. Am. J. Med. Sci. v.318 Iron absorption and transport Conrad, M. E.;J. N. Umbreit;E. G. Moore
  4. J. Parasitol. v.43 The establishment of various trichomonads of animals and man in axenic culture Diamond, L. S.
  5. Biotech. Histochem. v.72 The use of dimethylsulfoxide for fixation of yeast for electron microscopy Fassel, T.A.;P.G. Sohnle;V.M. Kushnaryov
  6. Rev. Prat. v.48 Vulvovaginitis Faurem M.;E. Drapier-Faure
  7. J. Fam. Pract v.41 Treatment of bacterial vaginosis: A comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream Ferris, D. G.;M. S. Litaker;L. Woodward;D. Mathis;J. Hendrich
  8. J. Fam. Pract. v.41 Office laboratory diagnosis of vaginitis. Clinician-performed tests compared with rapid nucleic acid hybridization test Ferris, D.G.;J. Hendrich;P.M. Payne;A. Getts;R. Rassekh;D. Mathis;M. S. Litaker
  9. Am. J. Trop. Med. Hyg. v.48 Iron chelation as a chemotherapeutic strategy for falciparum malaria Gordeuk, V.R.;P.E. Thuma;G.M. Brittenham;G. Biemba;S. Zulu;G. Simwanza;P. Kalense;A. M;Hango;D. Parry;A. A. Poltera, et al.
  10. Ophthalmologe v.92 Selective inhibition of replication of human cytomegalovirus by desferrioxamine in vitro and in vivo Gumbel, H.;J. Cinatl;H. Jr, Rabenau;J. U. Vogel;H. W. Doerr;C. Ohrloff
  11. Exp. Eye Res. v.44 Kinetic effects of metalion chelating reagents and their analogues on bovine lens aldehyde dehydrogenase Hoe, S. T.;M. J. Crabbe
  12. J. Neurosurg. v.88 Role of ferros iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage Horky, L. L.;R. M. Pluta;R. J. Boock;E. H. Oldfield
  13. Sabouraudia v.17 Effects of deferozamine methanesulfonate on Trichophyton mentagrophytes Kerbs, S.;R. Hutton;M. Lancaster
  14. J. Microbiol. Biotechnol. v.10 IL-6 mRNA expression in mouse macrophages and NIH 3T3 fibroblasts in response to Candida albicans Lee, Y. S.;H. S. Kim;S. K. Kim;S. D. Kim
  15. Science v.188 Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice Legator, M.S.;T.H. Connor;M. Stoeckel
  16. J. Exp. Med. v.174 The regulation of iron of the synthesis of adhesins and cytoadherence levels in the protozoan Trichomonas vaginalis Lehker, M. W.;R. Arroyo;J. F. Alderete
  17. Mol. Microbiol. v.6 Iron regulates growth of Trichomonas vaginalis and the expression of immunogenic trichomonad proteins Lehker, M. W.;J. F. Alderete
  18. Antimicrob. Agents Chemother. v.25 Susceptibilities of bacterial and fungal urinary tract isolated to desferrioxamine Lowy, F.D.;S. Pollack;N. Fadl-Allah;N. H. Steigbigel
  19. Acta Haematol v.95 Clinical studies of iron chelators in malaria Mabeza, G. F.;G. Biemba;V. R. Gordeuk
  20. Urol. Clin. North Am. v.19 Sexually transmitted protozoal infection: Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia Moldwin, R. M.
  21. Obstet. Gynecol. Surv. v.49 Bacterial vaginosis: Drugs versus alternative treatment Neri, A.;D. Rabinerson;B. Kaplan
  22. Clin. Microbiol. Rev. v.11 Clinical and microbiological aspects of Trichomonas vaginalis Petrin, D.;K. Delgaty;R. Bhatt;G. Garber
  23. Prostaglandins Leukot. Med. v.18 Comparative pharmacology of cyclooxygenase inhibitors on platelet function Rao, G. H.;J. G. White
  24. Biochem. Biophys. Res. Commun. v.66 Mutagenicity of metronidazole: Activation by mammalian liver microsomes Rosenkranz, H. S.;W. T. Speck
  25. Korean J. Parasitol. v.33 Effect on sodium nitrite on Trichomonas vaginalis Ryu, J.S.;J.W. Park;D.Y. Min
  26. J. Med. Microbiol. v.29 Gardnerella vaginalis has a Gram-positive cell wall ultrastructure and lacks classical cell-wall lipopolysaccharide Sadhu, K.;P.A.G. Dominigue;A. W. Chow;J. Nelligan;N. Cheng;J. W. Costerton
  27. N. Engl. J. Med. v.341 Metronidazole-resistant vaginal trichomoniasis- An emerging problem Sobel, J. D.;V. Nagappan;P. Nyitjesy
  28. J. Clin. Microbiol. v.15 Selective differential human blood bilayer media for isolation of Gardnerella (Haemophilus) vaginalis Tottern, P. A.;R. Amsel;J. Hale;P. Piot;K. K. Holmes
  29. ANtimicrob. Agents Chemother. v.35 Iron chelators as therapeutic agents aganist Pneumocystis carinii Weinberg, G. A.
  30. WHO Model Prescribing Information: Drugs used in Parasitic Diseases WHO
  31. J. Microbiol. Biotechnol. v.10 Encystation of Giardia lamblia by high bile and alkaline pH and its ultrastructural changes during encystation Yong, T. S.;H. W. Yang;K. I. Im;S. J. Park